• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter

    3/31/26 4:05:00 PM ET
    $EXOZ
    $MDBH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $EXOZ alert in real time by email

    Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025.

    More Detailed Information

    2025 Annual Shareholder Letter HERE.

    Form 10-K HERE.

    Key Assets and Strategic Developments

    • eXoZymes (NASDAQ:EXOZ): MDB holds approximately 4.1 million shares and warrants, valued at approximately $30 million based on March 30, 2026 market prices. The company is advancing cell-free biomanufacturing with large, ownable opportunities and clear commercialization timelines.
    • Paulex Bio: Closed a $19 million seed round during 2025, fully funding development. MDB holds approximately 7.1 million shares and warrants. Clinical trial initiation is expected later this year, with an IPO targeted for September 2026. The beta-cell regeneration platform has multi-billion-dollar potential across Type 1 and Type 2 diabetes.
    • PatentVest: Advancing toward spin-out as a standalone AI-enhanced IP law firm leveraging a 20-year proprietary patent database, ABS law-firm structure, and agentic AI for patent prosecution — positioned for significant value creation in the rapidly growing legal-tech sector.
    • MDB Direct (Public Ventures clearing platform): In active discussions for a strategic partnership that would realize value from this rare self-clearing asset while dramatically expanding distribution reach into individual-investor channels.
    • Additional equity positions were earned in HeartBeam and Buda Juice (recorded in 2026) through advisory services, positioning these small, profitable public companies for further growth.

    Financial Results

    • Annual fixed operating expenses ran at approximately $10 million for 2025, which includes $4 million investment in MDB Direct/Public Ventures clearing platform and PatentVest.
    • Net cash used for the full year was approximately $5.7 million.
    • At year-end, we also held approximately $22.3 million in cash, current assets, marketable securities less all liabilities
    • The Company is targeting improved cost/scale efficiencies as PatentVest and MDB Direct/Public Venture are spun off as independent entities.

    Fourth Quarter and Full Year 2025 Results Zoom Webinar at 4:30 p.m. ET Today

    Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period.

    Investors can register now for the Zoom webinar HERE. The live webinar can also be accessed on the day of the event through MDB's investor relations website at https://investors.mdb.com/.

    About MDB Capital Holdings, LLC

    Founded in 1997, MDB Capital focuses on launching category-defining disruptive technology companies through a unique public venture capital platform and approach. The firm emphasizes community-driven financings of early-stage leaders in significant business and technology categories via early public offerings, primarily on NASDAQ, as well as post-IPO offerings for qualifying companies. MDB Capital Holdings, LLC (NASDAQ:MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand. MDB Capital is a registered broker-dealer, Member FINRA/SIPC. For more information, please visit www.mdb.com

    Forward-Looking Statements

    This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

    Investor Relations Contact:

    [email protected]

    Media Contact:

    [email protected]



    Primary Logo

    Get the next $EXOZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EXOZ
    $MDBH

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $EXOZ
    $MDBH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Magennis Sean James was granted 10,000 shares, increasing direct ownership by 33% to 40,000 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    2/12/26 8:47:08 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    CFO James Jeremy William was granted 10,000 shares, increasing direct ownership by 50% to 29,839 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    2/12/26 8:44:10 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Director Torpey Daniel Thomas was granted 10,000 shares, increasing direct ownership by 37% to 37,100 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    2/12/26 8:41:57 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $EXOZ
    $MDBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Founder Marlett Christopher A bought $4,246 worth of shares (1,213 units at $3.50), increasing direct ownership by 0.72% to 169,933 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    1/5/26 8:24:36 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Co-Founder Marlett Christopher A bought $28,688 worth of shares (8,787 units at $3.26), increasing direct ownership by 6% to 166,720 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    12/31/25 4:34:29 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    President Brandon George Hugh bought $12,506 worth of shares (3,700 units at $3.38), increasing direct ownership by 4% to 105,248 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    12/11/25 7:59:02 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $EXOZ
    $MDBH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter

    Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025. More Detailed Information 2025 Annual Shareholder Letter HERE. Form 10-K HERE. Key Assets and Strategic Developments eXoZymes (NASDAQ:EXOZ): MDB holds approximately 4.1 million shares and warrants, valued at approximately $30 million based on March 30, 2026 market prices. The company is advancing cell-free biomanufacturing with large, ownable opportunities and clear commercialization

    3/31/26 4:05:00 PM ET
    $EXOZ
    $MDBH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Finance: Consumer Services
    Finance

    PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

    Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, "The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine." The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion in deal value has been committed across the amylin space, with major pharmaceutical companies, including Novo Nordisk, Eli Lilly, Roche, Pfizer, and AbbVie, actively building positions. The report highlights

    3/31/26 1:15:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork

    Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries. The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning, and long-term business value. Through this platform, PatentVest's legal and technical experts provide analysis on key patent law developments, practical prosecution strategies, and emerging trends shapin

    3/30/26 10:50:00 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $EXOZ
    $MDBH
    SEC Filings

    View All

    SEC Form 10-K filed by MDB Capital Holdings LLC

    10-K - MDB Capital Holdings, LLC (0001934642) (Filer)

    3/31/26 11:26:01 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    eXoZymes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - EXOZYMES INC. (0002010788) (Filer)

    3/31/26 6:12:00 AM ET
    $EXOZ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-K filed by eXoZymes Inc.

    10-K - EXOZYMES INC. (0002010788) (Filer)

    3/30/26 5:29:19 PM ET
    $EXOZ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $EXOZ
    $MDBH
    Leadership Updates

    Live Leadership Updates

    View All

    MDB Capital Holdings Announces Transitions In Its Board of Directors

    Addison, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading "Big Idea" companies, today announced the appointment of Jeb Terry, Sr to its Board of Directors and extended its sincere gratitude to Susanne Meline as she concluded her dedicated and influential board service. Both transitions are effective as of February 1, 2026. Jeb Terry brings to the MDB board more than two decades of investment in microcap medical and biotechnology companies, where he has consistently identified and capitalized on high-potential opportunities in this dynamic and innovation-driven sector. He founded and s

    2/2/26 7:30:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    MDB Capital Expands Board, Appoints Daniel Torpey as New Director

    Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB Capital"), a public venture platform focused on launching category-leading deep technology companies, today announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024. With the addition of Torpey, the MDB Capital Board now comprises eight members. Torpey brings over 24 years of experience at Ernst & Young LLP (EY), where he currently serves as an Assurance Partner in the Forensic & Integrity Services practice. His expertise spans accounting, auditing, compliance, financial reporting, fraud detection, and corporate investigations. "Dan's breadth of kn

    6/20/24 9:15:00 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $EXOZ
    $MDBH
    Financials

    Live finance-specific insights

    View All

    MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

    Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for

    3/23/26 9:45:00 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time

    Addison, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Thursday November 20, 2025 at 4:30 p.m. Eastern Time to provide a business update for the third quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

    11/11/25 9:00:00 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time

    Addison, TX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday August 27, 2025 at 4:30 p.m. Eastern Time to provide a business update for the second quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

    8/14/25 4:35:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance